FDA Removes Black Box Warnings on Estrogen Products
The FDA Just Corrected Course. Now It's Time to Correct the Language On November 10, 2025, the U.S. Food and Drug Administration announced it will remove the boxed ("black box") warnings from most...
Why Personalized Estradiol Dosing Matters
One Size Doesn't Fit All: Groupthink in Medicine May Be Leaving Women Behind Many women have long suspected that transdermal estradiol absorption is anything but predictable. Now, a groundbreaking...
Hormone Therapy & Breast Cancer Risk: What It Means for Adolescents and Young Women with Primary Ovarian Insufficiency
Latest NIH Analysis Researchers at the National Institutes of Health (NIH) analyzed data from more than 459,000 women under age 55 and found that: Absolute risk by age 55: ~3.6% (E-HT users) v...
Suspicious Minds: Understanding 17-Beta Estradiol
Understanding 17-Beta Estradiol Navigating menopause and the symptoms of 17-beta estradiol hormonal deficiency in young women with Primary Ovarian Insufficiency (POI) can be challenging, especiall...
Hormone Therapy and Biological Aging in Postmenopausal Women
Good News about Longevity and Women's Hormonal Health There is good news about the effects of hormone therapy on aging and longevity in women. Recent research has emerged with significant implicat...
